Applied DNA Distributor for Sweden Secures Contract Renewal with Prestige German Car Manufacturer
14 December 2017 - 9:30PM
Business Wire
DNA tagging program continues with aim of
preventing vehicle theft
Applied DNA Sciences, Inc. (NASDAQ: APDN; “Applied DNA”, “the
Company”), today announced the renewal of their contract to provide
SigNature® DNA via Safesolution SmartDNA AB, its Swedish
Distributor, to a prestige German car manufacturer to prevent
vehicle theft.
This announcement builds on the success of our previous
contract, which proved highly effective in preventing vehicle theft
of marked vehicles, and aiding in the recovery and identification
of stolen parts. The continuation of the program will ensure new
vehicles imported into Sweden will be protected.
As part of the program, high value components for all of the
manufacturer’s new cars are tagged with SigNature DNA (known as
Smart DNA® in Sweden) as they enter the country. Each vehicle is
tagged with a unique molecular code, enabling police to trace
stolen vehicles and components back to the original owner. The
program aims to keep insurance costs low for car owners and to
protect cars from criminals.
Tagging vehicles with SmartDNA has proved to be a powerful tool
for police. In the previous two years, DNA tagging has helped
police in a number of countries to gather forensic evidence and
intelligence on criminal networks.
“We are also working to deliver further value with our data
analytical capability to assist stakeholders in the reduction of
vehicle crime including vehicle owners, manufacturers, insurers and
law enforcement. This will add to the already powerful deterrence
value of SmartDNA,” said Tony Benson, Managing Director of Applied
DNA Sciences Europe.
Safesolution SmartDNA AB has been Applied DNA’s Swedish
distributor for the last 7 years. “The Prestige German Car
Manufacturer is a very demanding client who requires the very
highest service offerings for their customers. It is a great
pleasure to work with them and we are delighted to have been given
the opportunity to continue to build our relationship. We plan to
continually improve and enhance our service offerings to exceed
their expectations,” commented Leif Svensson, Founder and Chairman
of Safesolution SmartDNA AB.
SigNature DNA has been used in Europe since 2008 to deter crime
and convict criminals. To date, SigNature DNA evidence has been
used in conviction of over 115 criminals, leading to more than 540
years of prison time. Many more cases are still pending.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and therapeutics.
We make life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion. The proprietary DNA-based
“CertainT®” platform can be used to identify, tag, test, and track
products, to help assure authenticity, origin, traceability,
sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is
at the heart of a family of uncopiable, security and authentication
solutions such as SigNature® T and fiberTyping®, targeted toward
textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and
loss prevention, and digitalDNA®, providing powerful
track-and-trace. All provide a forensic chain of evidence, and can
be used to prosecute perpetrators. Applied DNA Sciences is also
engaged in the large-scale production of specific DNA sequences
using the polymerase chain reaction.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
The Company’s common stock is listed on NASDAQ under the symbol
APDN, and its warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe Applied DNA’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
APDN. Actual results could differ materially from those projected
due to our short operating history, limited financial resources,
limited market acceptance, market competition and various other
factors detailed from time to time in Applied DNA’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
6, 2016, and our subsequent quarterly reports on Form 10-Q filed on
February 9, 2017, May 11, 2017, and August 10, 2017 which are
available at www.sec.gov. Applied DNA undertakes no obligation to
update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to
reflect the occurrence of unanticipated events, unless otherwise
required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171214005152/en/
Investors:LHA Investor RelationsSanjay M. Hurry,
212-838-3777shurry@lhai.comorMedia:DGI CommCheryl
Schneider,
212-825-3210cschneider@dgicomm.comorProgram:Applied
DNA EuropeTony Benson, +1 44 (0) 7552 429341Managing
Directortony.benson@adnas.comorWeb: www.adnas.comTwitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2024 to May 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From May 2023 to May 2024